“…ABPs have also been applied to study the microbiome's modification of other host-produced metabolites, such as bile salts (Zhuang et al, 2017 ; Parasar et al, 2019 ), which have implications in the onset of diseases including cholestatic and inflammatory diseases, diabetes, and obesity (Wahlstrom et al, 2016 ). Microbial enzymes such as proteases, hydrolases, and β-glucuronidases have been labeled using various ABPs and applied successfully in investigating the changes in gut microbiome activity in different disease models (Hatzios et al, 2016 ; Mayers et al, 2017 ; Zhuang et al, 2017 ; Parasar et al, 2019 ; Whidbey et al, 2019 ; Jariwala et al, 2020 ). Importantly, these analyses reveal that change in microbial enzyme activity does not faithfully correspond to gene abundance, which reiterates the necessity of function-based analyses such as ABPP for researchers to harness the chemistry of the microbiome.…”